Literature DB >> 849189

Progressive multifocal leukoencephalopathy. A cause of visual loss.

R E Appen, H Roth, G M ZuRhein, J N Varakis.   

Abstract

A patient had been treated for chronic lymphocytic leukemia for five years before developing visual blurring as the manifestation of occipital lobe lesions of progressive multifocal leukoencephalopathy (PML). The disease is caused by an infection of the CNS oligodendrocytes by a papovavirus, whose replication is facilitated by an impairment of the host's cell-mediated immunologic system. The multiplying virus destroys the oligodendrocytes and causes extensive demyelination of the white matter of the brain. Antiviral agents, such as cytarabine, may be beneficial in treating patients with PML.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849189     DOI: 10.1001/archopht.1977.04450040122019

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  2 in total

1.  Isolated cortical blindness without simultaneous neurological involvement in progressive multifocal leukoencephalopathy in a patient with human immune deficiency virus infection.

Authors:  Vijay Ananth Jeyaraman; Sridharan Sudharshan; Ambika Selvakumar; Shika Bassi; Olma Veena Noronha; Poongulali Selvamuthu; Nagalingeshwaran Kumarasamy; Jyotirmay Biswas
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-03

2.  Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.

Authors:  Michela Spadaro; Marzia Caldano; Fabiana Marnetto; Alessandra Lugaresi; Antonio Bertolotto
Journal:  J Neuroinflammation       Date:  2015-08-12       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.